Tagged with Roundup,

China Pharma News: External Concern Over COVID-19 Outbreak; China Meheco Paxlovid Contract; Boston Scientific Stake in Acotec; Pfizer/LianBio Deal
Taiwan Biotech News: Gongwin-KY’s Lung Cancer Approval, Anxo Pharmaceutical/Genovior Alliance, Ever Supreme Bio’s Cell Therapy
Germany Pharma News: Merck’s Gamble on External Innovation, Boehringer Ingelheim/Surrozen Deal; Bayer CEO Priorities
Saudi Arabia Healthcare & Pharma News: Cinfa Expands Presence; Korean Investment Up; SPIMACO Funding Boost
India Pharma News: High Hopes for UK FTA; More FDA Warning Letters; 200 Million Covaxin Doses to Expire in 2023
Switzerland Healthcare & Pharma Roundup: Nine Million Moderna Vaccines Destroyed; Historic Health Insurance Rise; Altamira all-in on RNA
UK Pharma & Biotech Roundup: AbbVie Buys DJS; Clinical Trial Decline an ‘Existential’ Threat to British Research; MHRA Accelerated Pathway for Avrobio Gene Therapy
China Pharma News: Moderna Steadfast on mRNA IP; Advanced MedTech Buys WIKKON
Germany Pharma News: Bayer CEO on Thin Ice; Merck Manufacturing Expansion; STADA Launches First Rare Kidney Disease Drug
Netherlands Pharma News: Argenx to Go it Alone; Agendia Backs Out of IPO; Pleco AML Financing
China Pharma News: CanSino’s Inhaled COVID-19 Vaccine Approval; HitGen/Unison’s Anti-Infectives Deal; Neukio Biotherapeutics Funding
LatAm Pharma News: Indian Investment; Bayer Looks to Mexico; Brazilian Big Pharma Manufacturing
We use cookies to ensure that we give you the best experience on our site. For more info

See our Cookie Privacy Policy Here